Artificial Saliva Containing Cumin and Ginger Extract in Head and Neck Cancer Patients With Xerostomia

ConditionXerostomia

Trial statusNot yet recruiting

Trial phaseNot applicable

Trial typeInterventional

Biological sexAll

Age18+

SponsorChulalongkorn University

About this trial

The objectives of this study are to evaluate efficacy and safety of artificial saliva containing cumin and ginger extract in head and neck cancer patients with xerostomia.

Eligibility criteria

Qualifiers

Age more than 18 years

Head and neck cancer with xerostomia

6 months post radiation

Willing to participate in this study

Disqualifiers

Sialolith or Sjogren's syndrome

Uncontrolled cancer

Using artificial saliva more than 2 weeks

Taking Pilocarpine or cevimeline more than 2 weeks

Trial design

Treatments tested in this trial

Artificial saliva containing cumin and ginger extract
Placebo

Treatment groups

52 Participants

are divided into 2 treatment groups

Locations

This trial has no locations

Sponsors and collaborators

Chulalongkorn University

Lead sponsor

Source ClinicalTrials.gov